Pau Montesinos Selected Research

Hemorrhage

1/2022	Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.
1/2020	Advances in the management of coagulopathy in acute promyelocytic leukemia.
1/2020	Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience.
11/2019	Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
10/2011	Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
4/2010	Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
4/2008	Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
1/2007	Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pau Montesinos Research Topics

Disease

99	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2008
29	Acute Promyelocytic Leukemia 01/2021 - 01/2007
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 02/2014
15	Leukemia 08/2023 - 01/2007
13	Neoplasms (Cancer) 01/2023 - 01/2007
11	Philadelphia Chromosome 05/2024 - 10/2012
9	Febrile Neutropenia 01/2023 - 04/2009
9	Infections 01/2023 - 01/2007
8	Hemorrhage 01/2022 - 01/2007
7	Residual Neoplasm 05/2024 - 09/2014
7	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2007
7	Fever (Fevers) 01/2023 - 12/2007
7	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2007
7	Neutropenia 01/2023 - 06/2010
7	Pneumonia (Pneumonitis) 01/2023 - 12/2007
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 01/2019
4	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2021 - 09/2013
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 01/2016
3	Sepsis (Septicemia) 08/2021 - 04/2015
3	Mycoses (Diseases, Fungus) 09/2019 - 07/2015
2	Disease Progression 05/2024 - 03/2020
2	Burkitt Lymphoma (Burkitt's Lymphoma) 08/2023 - 05/2013
2	Pathologic Complete Response 03/2023 - 12/2020
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2020 - 11/2010
2	Obesity 03/2020 - 01/2020
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2020 - 06/2015
2	Thrombosis (Thrombus) 01/2020 - 01/2007
2	Drug-Related Side Effects and Adverse Reactions 03/2014 - 10/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2023
1	Breast Neoplasms (Breast Cancer) 02/2023
1	Hemoglobinopathies 01/2023
1	Trisomy (Trisomies) 01/2023
1	Diarrhea 01/2023

Drug/Important Bio-Agent (IBA)

26	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2023 - 02/2008
23	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 01/2007
22	AnthracyclinesIBA 01/2023 - 02/2008
15	Azacitidine (5 Azacytidine)FDA Link 10/2023 - 02/2016
8	fms-Like Tyrosine Kinase 3IBA 01/2023 - 10/2019
8	Arsenic Trioxide (Trisenox)FDA Link 01/2020 - 08/2008
7	venetoclaxIBA 03/2024 - 11/2020
7	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2018 - 04/2008
6	glasdegibIBA 10/2023 - 01/2019
6	gilteritinibIBA 02/2023 - 10/2019
5	Tyrosine Kinase InhibitorsIBA 05/2024 - 01/2019
4	midostaurinIBA 11/2023 - 01/2019
4	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2023 - 01/2019
4	quizartinibIBA 02/2023 - 01/2019
4	Retinoic Acid Receptor alphaIBA 10/2021 - 08/2008
4	fludarabineIBA 05/2021 - 01/2018
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017 - 10/2011
3	ponatinibIBA 05/2024 - 01/2022
3	Imatinib Mesylate (Gleevec)FDA Link 05/2024 - 10/2012
3	olutasidenibIBA 03/2024 - 01/2023
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024 - 01/2022
3	enasidenibIBA 03/2024 - 11/2021
3	Gemtuzumab (Mylotarg)FDA Link 01/2023 - 10/2020
3	Monoclonal AntibodiesIBA 12/2022 - 01/2021
3	Decitabine FDA Link 12/2022 - 01/2021
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 06/2015 - 09/2013
3	Drug CombinationsIBA 08/2014 - 10/2013
2	CPX-351IBA 05/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 07/2017
2	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 01/2022
2	RG7388IBA 01/2022 - 05/2020
2	selinexorIBA 12/2021 - 06/2021
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 06/2010
2	SteroidsIBA 08/2021 - 09/2013
2	cc-486IBA 12/2020 - 02/2016
2	Phosphotransferases (Kinase)IBA 11/2020 - 11/2012
2	Tyrosine (L-Tyrosine)FDA Link 11/2020 - 10/2011
2	AnticoagulantsIBA 01/2020 - 01/2007
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2018 - 01/2018
2	plerixafor FDA Link 05/2018 - 01/2018
2	Asparaginase (Elspar)FDA Link 01/2018 - 01/2017
2	Protein Isoforms (Isoforms)IBA 12/2013 - 10/2011
2	Busulfan (Busulfex)FDA Link 12/2013 - 09/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2009 - 12/2007
1	Inotuzumab OzogamicinIBA 09/2023
1	AnionsIBA 02/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2023
1	crenolanibIBA 02/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	BI 836858IBA 12/2022
1	AntigensIBA 08/2022
1	Adenosine Triphosphate (ATP)IBA 04/2022
1	Antineoplastic Agents (Antineoplastics)IBA 04/2022

Therapy/Procedure

50	Drug Therapy (Chemotherapy) 11/2023 - 01/2007
47	Therapeutics 12/2023 - 01/2007
23	Transplantation 03/2023 - 12/2007
10	Stem Cell Transplantation 01/2021 - 08/2007
9	Hematopoietic Stem Cell Transplantation 03/2023 - 02/2014
9	Induction Chemotherapy 04/2022 - 01/2012
4	Salvage Therapy 10/2021 - 06/2019
3	Precision Medicine 01/2023 - 08/2014
3	Cell Transplantation 01/2023 - 11/2017
3	Remission Induction 11/2020 - 04/2008
2	Consolidation Chemotherapy 01/2022 - 11/2018
1	Drug Tapering 08/2023